Related Experiment Videos
Protective effect on cisplatin hematotoxicity by procaine hydrochloride
M Esposito1, R Lerza, M Mencoboni
1Servizio di Farmacologia Tossicologica, University of Genoa, Italy.
Cancer Letters
|May 30, 1992
Summary
Procaine hydrochloride (P.HCl) mitigates cisplatin (DDP) induced hemotoxicity in mice, particularly at lower DDP doses. This study highlights P.HCl
Area of Science:
- Hematology
- Pharmacology
- Toxicology
Background:
- Cisplatin (DDP) is a widely used chemotherapeutic agent.
- DDP can cause significant hematological toxicity, affecting hematopoietic stem cells.
- Procaine hydrochloride (P.HCl) is being investigated for potential protective effects.
Purpose of the Study:
- To investigate the ability of P.HCl to modulate the hemotoxicity of DDP.
- To assess the impact of P.HCl on pluripotent (CFU-S) and committed (CFU-GM) murine hematopoietic stem cells.
Main Methods:
- DBA/2NCrlBRF1 mice were treated with DDP alone or in combination with P.HCl.
- Hematopoietic progenitor cell (HPC) survival was monitored up to 14 days post-treatment.
- Different doses of DDP (10 and 16 mg/kg) and a fixed dose of P.HCl (40 mg/kg) were administered.
Main Results:
- Simultaneous administration of P.HCl with a lower dose of DDP significantly reduced DDP-induced hemotoxicity.
- The protective effect of P.HCl was not significant when combined with a higher DDP dose.
- HPC time survival curves demonstrated a protective role for P.HCl.
Conclusions:
- P.HCl shows potential in protecting against cisplatin-induced hematological toxicity.
- The protective efficacy of P.HCl may be dose-dependent in relation to DDP.
- Further research into P.HCl as a supportive agent in chemotherapy is warranted.